The Pharma Data

MAY 19, 2023

HIGH SCHOOL SCIENTISTS AND ENGINEERS WIN NEARLY $9 MILLION AT THE REGENERON INTERNATIONAL SCIENCE AND ENGINEERING FAIR 2023 Regeneron Pharmaceuticals, Inc. I am humbled by the creativity and determination demonstrated by these exceptional students and proud of all they have accomplished with their outstanding research abilities.

Engineering 52

Engineering International Science Virus 52

Drug Target Review

OCTOBER 26, 2023

Genome engineering and gene therapies that manipulate DNA sequences in cells have driven a biotechnological revolution over the past decade. The limitations of natural AAV serotypes in meeting all clinical needs has spurred growing interest in AI-driven AAV engineering approaches. Nature reviews Drug discovery 18 , 358-378 (2019).

Engineering 105

Engineering Virus Therapies Immune Response 105

Sygnature Discovery

SEPTEMBER 14, 2023

Sygnature Discovery is delighted to announce that its customer, River BioMedics , has raised an additional €2M in seed funding to continue its life-saving cardiovascular drug research. The biotech’s aim is to develop medicines that treat the underlying cause of heart failure rather than merely treating the symptoms.

Small Molecule 52

Small Molecule Assay Development Disease Drug Research 52

The Pharma Data

NOVEMBER 10, 2020

As the powerful discovery engine of the company, Innovent Academy is committed to focusing on the first-in-class innovation with unmet medical need. In addition, in order to achieve next level strategic goal of developing global first-in-class product in 5-10 years, Innovent Academy has been established.

Biosimilars 52

Biosimilars Clinical Trials International Clinical Development 52

DrugBank

FEBRUARY 12, 2025

CMap utilizes gene expression profiles to connect drugs, genes, and diseases, enabling researchers to identify potential repurposing candidates based on their transcriptional signatures. DrugBank data is not only valuable for manual exploration but also serves as a powerful engine for computational drug repurposing.

Cell Based Assays 52

Cell Based Assays Drugs Pharmacokinetics Disease 52

Codon

JUNE 2, 2024

While fundamental research is often productive in mice, translational drug research tends to be relatively intolerant to biological differences. This allowed researchers to easily engineer mice by editing the stem cells, and then injecting the edited cells into a mouse embryo.

Laboratories 130

Laboratories Research Disease Science 130

Drug Target Review

FEBRUARY 11, 2025

New era in drug research: data access and NGS The 1990s and 2000s marked a turning point in the drug development landscape, facilitated by a combination of cultural and technological factors that enabled regulatory changes, technological innovations and methodological advances.

Drug Development 59

Drug Development Bioinformatics Drugs Small Molecule 59